‏792.00 ₪

NEUROENDOCRINE TUMOURS DIAGNOSIS AND MANAGEMENT

‏792.00 ₪
ISBN13
9783662452141
יצא לאור ב
Berlin, Heidelberg
מהדורה
2015 ed.
עמודים / Pages
578
פורמט
Hardback
תאריך יציאה לאור
1 ביוני 2015
This book is a timely textbook that covers all aspects of neuroendocrine tumors (NET) from epidemiology, pathological classification and evaluation and molecular biology through to diagnostic imaging methods and therapeutic options, including the latest targeted therapies.
This book is a timely textbook that covers all aspects of neuroendocrine tumors (NET) from epidemiology, pathological classification and evaluation and molecular biology through to diagnostic imaging methods and therapeutic options, including the latest targeted therapies. The various types of NET are individually discussed, including carcinoid tumors, insulinomas, gastrinomas, glucagonomas, VIPomas, somatostatinomas, PPomas, medullary thyroid carcinomas, adrenocortical cancer, pheochromocytomas, paragangliomas and non-functioning pancreatic NETs. The contributing authors are internationally recognized experts who bring a wealth of experience to the subject. This book will be an invaluable source of information for practicing medical oncologists, surgeons, endocrinologists, gastroenterologists and pathologists and also trainees.
מידע נוסף
מהדורה 2015 ed.
עמודים / Pages 578
פורמט Hardback
ISBN10 3662452146
יצא לאור ב Berlin, Heidelberg
תאריך יציאה לאור 1 ביוני 2015
תוכן עניינים Introduction.- Historical Background.- Epidemiology.- Pathological Classification.- Carcinoid Syndrome.- Molecular Biology.- Insulinoma.- Gastrinoma.- Vipoma.- Glucagonoma.- Pathological Evaluation.- Radiological Imaging.- Nuclear Imaging.- Genetic Syndromes Associated with NET.- Surgical Approach.- Locoregional treatment (RFA).- Embolization (Chemo/radio).- PRRT.- Management of Hormonal symptoms.- Chemotherapy.- Somatostatin Analogues.- Targeted Therapies.- Guidelines.- Societies and Guidelines.- Biomarkers.- Medullary Thyroid Cancer.- Adrenocortical Cancer.- Paraganglioma, feokromositoma.- Nonfonksiyone pNET.- Somatostatinoma.- Poorly differentiated NET.- Management of MEN.- Ppoma.